
VolitionRx Limited VNRX
€ 0.17
-0.11%
Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025
VolitionRx Limited DSO 2011-2026 | VNRX
DSO Jährlich VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.3 | 74.2 | 50.7 | 39.8 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 74.2 | 39.8 | 54.2 |
DSO Vierteljährlich VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.3 | 42.3 | 55.3 | - | 46 | 34.5 | 100 | - | 63.8 | 66.5 | 58.2 | - | 19.5 | 92.8 | 33.9 | - | 63.4 | 55.4 | 38.2 | - | 1.13 K | 125 | 597 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.9 | 107 | 45.6 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.13 K | 19.5 | 135 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
82.1 | $ 8.98 | 1.18 % | $ 598 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 26.0 | 0.64 % | $ 722 M | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
87 | $ 68.09 | 2.64 % | $ 26.6 B | ||
|
Guardant Health
GH
|
46.1 | $ 88.7 | 1.74 % | $ 11.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 155.4 | 2.26 % | $ 7.7 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.57 | 1.44 % | $ 936 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 101.48 | 3.96 % | $ 8.37 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 169.45 | 2.77 % | $ 29.1 B | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | $ 103.94 | 0.08 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.65 | 4.65 % | $ 473 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
41.7 | $ 17.5 | 1.21 % | $ 2.27 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.88 | 1.23 % | $ 93.5 K | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.37 | 2.85 % | $ 2.03 B | ||
|
Danaher Corporation
DHR
|
55.3 | $ 194.76 | 1.76 % | $ 139 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.4 | 3.16 % | $ 420 M | ||
|
Illumina
ILMN
|
61.3 | $ 121.73 | 2.05 % | $ 19.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 199.39 | 0.23 % | $ 22.1 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
63.8 | $ 113.69 | 1.66 % | $ 34.6 B | ||
|
BioNano Genomics
BNGO
|
83.4 | $ 1.12 | 0.9 % | $ 1.42 M | ||
|
DarioHealth Corp.
DRIO
|
85.8 | $ 9.28 | 10.24 % | $ 263 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 78.71 | 0.26 % | $ 5.31 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
101 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 457.78 | 0.91 % | $ 13.2 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 218.18 | 1.62 % | $ 25.1 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 46.28 | 2.82 % | $ 2.77 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.07 | 3.85 % | $ 404 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.41 | 2.06 % | $ 1.08 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
81.5 | $ 201.38 | 1.87 % | $ 19.8 B |